Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 4.7.2023Teva B.V. (TEV-NL-4)4961BBrieka 150 mg (cps dur 56x150 mg (blis.Al/PVC))15.7.2023Z
 4.7.2023Teva B.V. (TEV-NL-4)90389Carvedilol-Teva 6,25 mg (tbl 30x6,25 mg (blis.PVC/PVDC/Al))26.7.2023R
 4.7.2023Teva B.V. (TEV-NL-4)91364Gabapentin-Teva 100 mg (cps dur 100x100 mg (blis.PVC/PVDC/Al))26.7.2023R
 3.7.2023Warszawskie Zaklady Farmaceutyczne Polfa S.A. (WZF)11706BISEPTOL 480 (con inf 10x5 ml)26.6.2023O
 2.7.2023Sanofi Winthrop Industrie (SWI-11)11853Depakine Chrono 500 mg (tbl flp 30x500 mg (tuba PP))4.7.2023R
 30.6.2023BELUPO, s.r.o. (BLU-SK)20379URUTAL 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))30.6.2023R
 30.6.2023BELUPO, s.r.o. (BLU-SK)38084URUTAL 16 mg (tbl 60x16 mg (blis.PVC/PVDC/Al))30.6.2023R
 29.6.2023Desitin Arzneimitttel GmbH (DET)2469BPhenaemaletten (tbl 50x15 mg (obal PE biely))30.6.2023R
 29.6.2023Desitin Arzneimitttel GmbH (DET)45241isicom 100 mg (tbl 100x100 mg/25 mg (blis.PP/Al))30.9.2023R
 29.6.2023Dr Falk Pharma GmbH (FAK-1)6908CJorveza 1 mg orodispergovateľné tablety (tbl oro 90x1 mg (blis.Al/Al))1.9.2023U
 29.6.2023KRKA, d.d., Novo mesto (KRK-2)37040Finpros 5 mg (tbl flm 100x5 mg (blis.PVC/Al))10.7.2023O
 29.6.2023Dr Falk Pharma GmbH (FAK-1)4726DJorveza 0,5 mg orodispergovateľné tablety (tbl oro 90x0,5 mg (blis.Al/Al))1.9.2023U
 28.6.2023HEATON k.s. (HTN-3)2440ESokar 8 mg tablety s predĺženým uvoľňovaním (tbl plg 100x8 mg (blis.OPA/Al/PVC/Al-neperfor.))28.6.2023U
 28.6.2023Fresenius Kabi s.r.o. (FRK-CZ-3)76541Piperacillin/Tazobactam Kabi 4 g/0,5 g (plv ifo 10x4 g/0,5 g (liek.inj.skl.))29.6.2023O
 28.6.2023Fresenius Kabi AB (FRE)13115DIPEPTIVEN (con inf 10x100 ml (fľ.skl.))1.7.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)